Skip to content

Effectiveness of ramosetron in preventing post-operative nausea and vomiting: a systematic review and meta-analysis with trial sequential analysis

Effectiveness of ramosetron in preventing post-operative nausea and vomiting: a systematic review and meta-analysis with trial sequential analysis - Effectiveness of ramosetron in preventing post-operative nausea and vomiting: a systematic review and meta-analysis with trial sequential analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000016977
Enrollment
Unknown
Registered
2015-04-01
Start date
2015-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who underwent surgery with general anesthesia

Interventions

None listed

Sponsors

Yokohama City University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: all double-blinded randomized controlled trials that tested the efficacy of ramosetron compared with a placebo or other drug as a control in the prophylaxis of PONV

Exclusion criteria

Exclusion criteria: Studies which were reported by Fujii et al. Studies which did not include details of PON and/or POV, or the early and/or late periods. Data from case reports, comments or letters to the editor, reviews, and animal studies.

Design outcomes

Primary

MeasureTime frame
The primary outcome from the present meta-analysis concerned PON and POV between ramosetron and ondansetron or a placebo in the early and/or late periods (defined later in this section).

Countries

Japan

Contacts

Public ContactTakahiro Mihara

Yokohama City University Graduate School of Medicine Department of Anesthesiology and Critical Care Medicine

miharaxxxtotoro@yahoo.co.jp045-787-2800

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026